NCT05783245 Effect of Cooling Therapy for Post-Operative Pain in Open Carpal Tunnel Release
| NCT ID | NCT05783245 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chicago |
| Condition | Carpal Tunnel Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 128 participants |
| Start Date | 2023-06-01 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 128 participants in total. It began in 2023-06-01 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study seeks to perform an appropriately-powered study to evaluate any clinical difference between continuous cooling therapy and traditional ice for treatment of post-operative pain in open CTR surgery.
Eligibility Criteria
Inclusion Criteria: 1. Age 18 or older 2. Indicated for open carpal tunnel release 3. Able and willing to complete online questionnaires Exclusion Criteria: 1. Prior carpal tunnel surgery for ipsilateral extremity 2. Additional procedures to be performed on ipsilateral or contralateral extremity 3. Current opioid or narcotic pain medication usage
Contact & Investigator
Jennifer Wolf, MD
PRINCIPAL INVESTIGATOR
University of Chicago
Frequently Asked Questions
Who can join the NCT05783245 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Carpal Tunnel Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05783245 currently recruiting?
Yes, NCT05783245 is actively recruiting participants. Contact the research team at Patrick.Nelson@uchospitals.edu for enrollment information.
Where is the NCT05783245 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT05783245 clinical trial?
NCT05783245 is sponsored by University of Chicago. The principal investigator is Jennifer Wolf, MD at University of Chicago. The trial plans to enroll 128 participants.